Innovation Center for Bio Technology

Pharmaceutical company "Innovation Center for Bio Technology" is created for the organization of serial production and sales of original and combined immunobiological drugs, and other pharmaceuticals (generics), scheduled to launch in the near future. Level, area and production capacity possessed by our company, allow to manufacture the drugs in conditions that meet the requirements of GMP, in an amount sufficient to fill the market of import substitution.

Development and production of original combined preparations on the basis of a combination of a complex of immunoglobulins:

• with naphazoline or phenylephrine (nasal variant);
• with ofloxacin (eye version).

The production of immunoglobulin complex preparation Triglobin containing serum immunoglobulin classes IgG, IgA and IgM with high specific activity against herpes viruses, rotaviruses, adenoviruses, influenza, chlamydia, staphylococci, enterobacteria (Shigella, Salmonella, Escherichia) and other pathogenic microorganisms. The drug is effective in the treatment of acute intestinal infections of various etiologies.
As well as the production of generic drugs (generic drugs):

• in the form of nasal drops and spray on the basis of naphazoline (similar Senorina) or phenylephrine (an analogue of Vibrocila), used as a decongestant in the treatment of rhinitis, sinusitis, pollinosis;
• in the form of eye drops on the basis of ofloxacin (similar Floxal), used as an antibacterial agent in the treatment of conjunctivitis, blepharitis, etc.